Hai-Tao Zhao
Hai-Tao Zhao
Beijing, Beijing Municipality, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Cadonilimab and Lenvatinib for Conversion Therapy in Unresectable Hepatocellular Carcinoma | Cadonilimab and Lenvatinib | Recruiting | Phase 2 | 2024-04-01 | NCT06215651 |